CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-23 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +2,400 | $4.56 | $11K | 2,315,252 |
| 2026-02-03 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +688,000 | 688,000 | ||
| 2025-07-02 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +7,015 | $3.53 | $25K | 2,312,852 |
| 2025-07-01 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +2,985 | $3.38 | $10K | 2,305,837 |
| 2025-06-18 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +21,000 | $2.39 | $50K | 2,302,852 |
| 2025-02-05 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +480,000 | 480,000 | ||
| 2024-03-19 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +20,000 | $2.77 | $55K | 2,281,852 |
| 2024-02-08 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +244,286 | 244,286 | ||
| 2024-02-08 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +16,414 | 16,414 | ||
| 2023-02-15 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +352,244 | 352,244 | ||
| 2023-02-15 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +21,756 | 374,000 | ||
| 2022-12-22 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion | +2,500 | $3.01 | $8K | 2,261,852 |
| 2022-12-22 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion · Stock Option | −2,500 | 203,500 | ||
| 2022-04-12 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion | +2,000 | $3.01 | $6K | 2,259,352 |
| 2022-04-12 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion · Stock Option | −2,000 | 206,000 | ||
| 2022-03-23 | Zeskind Benjamin J. PRESIDENT AND CEO | Purchase | +3,000 | $8.02 | $24K | 2,257,352 |
| 2022-02-28 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion | +2,000 | $3.01 | $6K | 2,254,352 |
| 2022-02-28 | Zeskind Benjamin J. PRESIDENT AND CEO | Exercise or conversion · Stock Option | −2,000 | 208,000 | ||
| 2022-02-10 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +156,485 | 156,485 | ||
| 2022-02-10 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +45,615 | 202,100 |
Page 1 of 2 · 25 trades